Patents by Inventor Antonio Romero

Antonio Romero has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240158372
    Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.
    Type: Application
    Filed: August 17, 2023
    Publication date: May 16, 2024
    Inventors: Luke ASHCRAFT, Alessandro BOEZIO, John BUTLER, Aroop CHANDRA, Chihyuan CHUANG, Scott E. COLLIBEE, Mikkel DEBENEDETTO, Vincent DIMASSA, Russell GRACEFFA, Justin MALINOWSKI, David MOEBIUS, Bradley P. MORGAN, Joshua PAYETTE, Antonio ROMERO, David ST. JEAN, JR., Richard VARGAS, John YEOMAN, Hanmo ZHANG, Alan CHENG, Felix GONZALEZ LOPEZ DE TURISO, Michael Garrett JOHNSON
  • Patent number: 11962044
    Abstract: The present invention offers some general specifications for the design, assembly, and adaptation of a rotating cylinder electrochemical cell into an autoclave, of a high temperature and pressure system for corrosion studies that simulate operating conditions in pipelines, as well as the operation and safety of an autoclave to evaluate the electrochemical process of metal surfaces exposed to aggressive aqueous solutions. The electrochemical cell consists of an array of three electrodes that include a rotating cylinder electrode designed to operate hermetically, a reference electrode and an auxiliary electrode. The rotating cylinder electrode is considered to be the working electrode, where the oxidation and electrochemical reduction processes are studied. However, the use of the method described in this work can be extended to other testing environments and materials by taking into account the physical and chemical properties of the fluids and materials to be used in order to avoid any risk for the operator.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: April 16, 2024
    Assignee: INSTITUTO MEXICANO DEL PETROLEO
    Inventors: Eliceo Sosa Hernandez, Marco Antonio Dominguez Aguilar, Hongbo Liu, Jorge Luis Alamilla Lopez, Jorge Flores Castillo, Marco Antonio Hernandez Rojo, Ivan Velazquez Ovando, Cesar Mendez Romero, Luis Manuel Quej Ake
  • Publication number: 20240067631
    Abstract: Provided herein are compounds of formula (A): or a pharmaceutically acceptable salt thereof, wherein X, R1, R2, R3, R4, Ry, and Rz are as defined herein. Also provided herein is a pharmaceutically acceptable composition comprising a compound of formula (A), or a pharmaceutically acceptable salt thereof, as well as methods of using a compound of formula (A), or a pharmaceutically acceptable salt thereof, to treat various diseases and conditions mediated by nicotinamide phosphoribosyltransferase (NAMPT).
    Type: Application
    Filed: December 20, 2021
    Publication date: February 29, 2024
    Inventors: Minxing SHEN, Antonio ROMERO, Pu-Ping LU
  • Publication number: 20240019502
    Abstract: A system includes: an electrical apparatus that includes: a housing that defines an interior space; an active portion in the interior space; and insulation configured to electrically insulate at least part of the active portion. The system also includes a monitoring apparatus configured to: receive measured data from the electrical apparatus; determine a load forecast for the electrical apparatus based on the measured data; determine whether a pre-determined time interval has elapsed; and after the pre-determined time interval has elapsed: estimate an actual amount of life lost for the insulation during the pre-determined time interval that elapsed based on the measured data; estimate a predicted amount of life lost for the insulation during one or more future time intervals based on the load forecast; and estimate a remaining service life for the electrical apparatus based on the actual amount of life lost and the predicted amount of life lost.
    Type: Application
    Filed: June 30, 2023
    Publication date: January 18, 2024
    Inventors: Bubathi Muruganantham, Prasad Arvind Venikar, Balachandar D, Mugdha Vyankatesh Limaye, Mark Andre Faulkner, Travis Vernon Spoone, Robert Edward Page, Antonio Romero Oruga, Swetha Prakash
  • Publication number: 20240011847
    Abstract: An electrical apparatus includes: a housing that defines an interior space; an active portion in the interior space, the active portion including one or more electrically conductive coils; a fluid in the interior; and a control system configured to: determine a difference between a measured temperature of the fluid and an estimated temperature of the fluid; and determine whether a performance condition exists based on the difference.
    Type: Application
    Filed: June 30, 2023
    Publication date: January 11, 2024
    Inventors: Bubathi Muruganantham, Prasad Arvind Venikar, Balachandar D, Mugdha Vyankatesh Limaye, Mark Andre Faulkner, Travis Vernon Spoone, Robert Edward Page, Antonio Romero Oruga, Swetha Prakash
  • Publication number: 20230348369
    Abstract: Provided are compounds of Formula (II): or a pharmaceutically acceptable salt thereof, wherein R1, n, and Y1 are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (II), or a pharmaceutically acceptable salt thereof. Also provided are methods of using a compound of Formula (II), or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 5, 2021
    Publication date: November 2, 2023
    Inventors: Antonio ROMERO, Aroop CHANDRA, Christopher EVANS, Minxing SHEN
  • Publication number: 20230335302
    Abstract: Systems and methods are provided that facilitate stability of an FRC plasma in both radial and axial directions and axial position control of an FRC plasma along the symmetry axis of an FRC plasma chamber. The systems and methods exploit an axially unstable equilibria of the FRC plasma to enforce radial stability, while stabilizing or controlling the axial instability. The systems and methods provide feedback control of the FRC plasma axial position independent of the stability properties of the plasma equilibrium by acting on the voltages applied to a set of external coils concentric with the plasma and using a non-linear control technique.
    Type: Application
    Filed: February 24, 2023
    Publication date: October 19, 2023
    Inventor: Jesus Antonio Romero Gonzalez
  • Patent number: 11780826
    Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.
    Type: Grant
    Filed: February 15, 2022
    Date of Patent: October 10, 2023
    Assignees: AMGEN INC., CYTOKINETICS, INC.
    Inventors: Luke Ashcraft, Alessandro Boezio, John Butler, Aroop Chandra, Chihyuan Chuang, Scott E. Collibee, Mikkel Debenedetto, Vincent Dimassa, Russell Graceffa, Justin Malinowski, David Moebius, Bradley P. Morgan, Joshua Payette, Antonio Romero, David St. Jean, Jr., Richard Vargas, John Yeoman, Hanmo Zhang, Alan Cheng, Felix Gonzalez Lopez De Turiso, Michael Garrett Johnson
  • Publication number: 20230280415
    Abstract: A system includes a monitoring module configured to: receive a first indication related to a three-phase input of a three-phase AC electrical asset; receive a second indication related to a three-phase output of the three-phase AC electrical asset; determine performance metrics for the three-phase AC electrical asset based on the first indication and the second indication; determine error metrics by comparing each determined performance metrics to a pre-determined estimated performance metric; compare each of the error metrics to one of a plurality of pre-determined thresholds, the thresholds being determined when the three-phase AC electrical asset is in a healthy condition; and determine whether a developing fault condition exists in the three-phase AC electrical asset based on the comparison.
    Type: Application
    Filed: February 27, 2023
    Publication date: September 7, 2023
    Inventors: Prasad Arvind Venikar, Bubathi Muruganantham, Mugdha Vyankatesh Limaye, Bibhudatta Patnaik, Mark Andre Faulkner, Travis Vernon Spoone, Robert Edward Page, Antonio Romero Oruga
  • Publication number: 20230133132
    Abstract: Provided are compounds of Formula (II) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, and p are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (II), or a pharmaceutically acceptable salt thereof. Also provided are methods of using a compound of Formula (II), or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 5, 2021
    Publication date: May 4, 2023
    Inventors: Antonio ROMERO, Aroop CHANDRA, Christopher Edward EVANS, Minxing SHEN
  • Patent number: 11615896
    Abstract: Systems and methods are provided that facilitate stability of an FRC plasma in both radial and axial directions and axial position control of an FRC plasma along the symmetry axis of an FRC plasma chamber. The systems and methods exploit an axially unstable equilibria of the FRC plasma to enforce radial stability, while stabilizing or controlling the axial instability. The systems and methods provide feedback control of the FRC plasma axial position independent of the stability properties of the plasma equilibrium by acting on the voltages applied to a set of external coils concentric with the plasma and using a non-linear control technique.
    Type: Grant
    Filed: November 12, 2021
    Date of Patent: March 28, 2023
    Assignee: TAE TECHNOLOGIES, INC.
    Inventor: Jesus Antonio Romero Gonzalez
  • Publication number: 20230026651
    Abstract: Provided are compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X and m are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof. Also provided are methods of using a compound of Formula I, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 20, 2022
    Publication date: January 26, 2023
    Inventors: Zhe YANG, Alex R. MUCI, Jeffrey WARRINGTON, Gustave BERGNES, Bradley P. MORGAN, Chihyuan CHUANG, Antonio ROMERO, Scott COLLIBEE, Xiangping QIAN, Pu-Ping LU
  • Publication number: 20220332708
    Abstract: The present disclosure relates to sulfonamide compounds and pharmaceutically acceptable salts thereof as cardiac sarcomere activators.
    Type: Application
    Filed: April 5, 2022
    Publication date: October 20, 2022
    Inventors: Jeffrey GARDINA, Aroop CHANDRA, Luke W. ASHCRAFT, Scott COLLIBEE, Chihyuan CHUANG, Alex MUCI - DECEASED, Bradley P. MORGAN, Antonio ROMERO, Michael JOHNSON, David MOEBIUS, Hanmo ZHANG, Felix GONZALEZ
  • Publication number: 20220281850
    Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.
    Type: Application
    Filed: February 15, 2022
    Publication date: September 8, 2022
    Inventors: Luke ASHCRAFT, Alessandro BOEZIO, John BUTLER, Aroop CHANDRA, Chihyuan CHUANG, Scott E. COLLIBEE, Mikkel DEBENEDETTO, Vincent DIMASSA, Russell GRACEFFA, Justin MALINOWSKI, David MOEBIUS, Bradley P. MORGAN, Joshua PAYETTE, Antonio ROMERO, David ST. JEAN, JR., Richard VARGAS, John YEOMAN, Hanmo ZHANG, Alan CHENG, Felix GONZALEZ LOPEZ DE TURISO, Michael Garrett JOHNSON
  • Patent number: 11369565
    Abstract: Provided are compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X and mare as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof. Also provided are methods of using a compound of Formula I, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: July 28, 2020
    Date of Patent: June 28, 2022
    Assignee: CYTOKINETICS, INC.
    Inventors: Zhe Yang, Alex R. Muci, Jeffrey Warrington, Gustave Bergnes, Bradley P. Morgan, Chihyuan Chuang, Antonio Romero, Scott Collibee, Xiangping Qian, Pu-Ping Lu
  • Patent number: 11299479
    Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.
    Type: Grant
    Filed: October 12, 2020
    Date of Patent: April 12, 2022
    Assignees: CYTOKINETICS, INC., AMGEN INC.
    Inventors: Luke Ashcraft, Alessandro Boezio, John Butler, Aroop Chandra, Chihyuan Chuang, Scott E. Collibee, Mikkel V. Debenedetto, Vincent DiMassa, Russell Graceffa, Justin Malinowski, David Moebius, Bradley Paul Morgan, Joshua Payette, Antonio Romero, David St. Jean, Jr., Richard Vargas, John Yeoman, Hanmo Zhang, Alan Cheng, Felix Gonzalez Lopez De Turiso, Michael Garrett Johnson
  • Publication number: 20220068510
    Abstract: Systems and methods are provided that facilitate stability of an FRC plasma in both radial and axial directions and axial position control of an FRC plasma along the symmetry axis of an FRC plasma chamber. The systems and methods exploit an axially unstable equilibria of the FRC plasma to enforce radial stability, while stabilizing or controlling the axial instability. The systems and methods provide feedback control of the FRC plasma axial position independent of the stability properties of the plasma equilibrium by acting on the voltages applied to a set of external coils concentric with the plasma and using a non-linear control technique.
    Type: Application
    Filed: November 12, 2021
    Publication date: March 3, 2022
    Inventor: Jesus Antonio Romero Gonzalez
  • Patent number: 11254658
    Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.
    Type: Grant
    Filed: March 27, 2020
    Date of Patent: February 22, 2022
    Assignees: Amgen Inc., Cytokinetics, Inc.
    Inventors: Mikkel V. Debenedetto, Justin Malinowski, Joshua Payette, Antonio Romero, David St. Jean, Jr.
  • Patent number: 11217351
    Abstract: Systems and methods are provided that facilitate stability of an FRC plasma in both radial and axial directions and axial position control of an FRC plasma along the symmetry axis of an FRC plasma chamber. The systems and methods exploit an axially unstable equilibria of the FRC plasma to enforce radial stability, while stabilizing or controlling the axial instability. The systems and methods provide feedback control of the FRC plasma axial position independent of the stability properties of the plasma equilibrium by acting on the voltages applied to a set of external coils concentric with the plasma and using a non-linear control technique.
    Type: Grant
    Filed: May 10, 2018
    Date of Patent: January 4, 2022
    Assignee: TAE TECHNOLOGIES, INC.
    Inventor: Jesus Antonio Romero Gonzalez
  • Publication number: 20210045997
    Abstract: Provided are compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X and mare as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof. Also provided are methods of using a compound of Formula I, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 28, 2020
    Publication date: February 18, 2021
    Inventors: Zhe YANG, Alex R. MUCI, Jeffrey WARRINGTON, Gustave BERGNES, Bradley P. MORGAN, Chihyuan CHUANG, Antonio ROMERO, Scott COLLIBEE, Xiangping QIAN, Pu-Ping LU